Because ∼40% of PCas express epidermal growth factor receptor (EGFR), expression of which is correlated with tumour recurrence and high Gleason score, the receptor is assumed to be a potential molecular target for advanced PCa. Here, EGFR is linked to posterior cortical atrophy.